We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Chemoresistance as a function of the pretherapy tumor burden and the chemotherapy regimen administered: differences observed with 2 current chemotherapy regimens for advanced Hodgkin lymphoma.
- Authors
Gobbi, Paolo G; Valentino, Francesco; Bassi, Emilio; Coriani, Chiara; Merli, Francesco; Bonfante, Valeria; Marchianò, Alfonso; Gallamini, Andrea; Bolis, Silvia; Stelitano, Caterina; Levis, Alessandro; Federico, Massimo; Angrilli, Francesco; Di Giulio, Giuseppe; Corazza, Gino R
- Abstract
The mature results from trials comparing ABVD (Adriamycin [doxorubicin], bleomycin, vinblastine, dacarbazine) and BEACOPP (bleomycin, etoposide, Adriamycin [doxorubicin], cyclophosphamide, Oncovin [vincristine], procarbazine, prednisone) chemotherapies in advanced Hodgkin lymphoma will be available in some years. An early comparison of their curative potential can however be obtained from an assessment of initial tumor burden and chemoresistance.
- Publication
Clinical lymphoma, myeloma & leukemia, 2011, Vol 11, Issue 5, p396
- ISSN
2152-2669
- Publication type
Journal Article
- DOI
10.1016/j.clml.2011.04.008